Get the Stockscreener App
0.9097
1.08%
0.0097
Pre-market:
.91
0.0003
+0.03%
Mustang Bio Inc stock is traded at $0.9097, with a volume of 52,784.
It is up +1.08% in the last 24 hours and down -18.05% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$0.90
Open:
$0.86
24h Volume:
52,784
Relative Volume:
0.28
Market Cap:
$6.64M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0117
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
+27.73%
1M Performance:
-18.05%
6M Performance:
-46.49%
1Y Performance:
-68.30%
1-Day Range:
$0.8251
$0.91
1-Week Range:
$0.64
$0.91
52-Week Range:
$0.5306
$7.00
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.9097 | 6.57M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
T-cell Therapy Market is Expected to Grow USD 15.3 Billion by 2033 | At CAGR 15.11% - vocal.media
US Market Wrap: Will Akoya Biosciences Inc benefit from green energy policiesTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Setups: Will SHRFP benefit from government policyMarket Growth Review & Growth Oriented Trading Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Aug Rallies: Does Mustang Bio Inc have a sustainable dividendEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
MACD Signal: What is OneMain Holdings Incs debt to equity ratioWeekly Profit Summary & Momentum Based Trading Ideas - baoquankhu1.vn
Mustang Bio sells assets and ends lease with AbbVie - MSN
Can Mustang Bio Inc. sustain its profitability2025 Sector Review & Daily Chart Pattern Signals - mfd.ru
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy - The Medicine Maker
CEO Moves: Can Mustang Bio Inc sustain its profitabilityJuly 2025 PostEarnings & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Technicals: Does Mustang Bio Inc have pricing power2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Returns Recap: How is ARRY managing supply chain issues2025 Historical Comparison & Safe Entry Momentum Tips - baoquankhu1.vn
Why millennials buy Thor Industries Inc. stockQuarterly Investment Review & Consistent Return Strategy Ideas - bollywoodhelpline.com
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant
Aug Highlights: What is GDS Holdings Limited Depositary Receipts revenue forecastJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Momentum Screeners Rank Haria Exports Limited in Top 5 TodayEconomic Impact on Stocks & Minimal Investment Trading - Bollywood Helpline
Published on: 2026-01-11 00:49:59 - Bộ Nội Vụ
Why analysts remain bullish on Mustang Bio Inc. stock2025 Volatility Report & High Accuracy Swing Trade Signals - Улправда
How strong dollar benefits Zinc One Resources Inc. (RH3) stock2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Will Mustang Bio Inc. stock gain from strong economy2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
2026 world cup match report pre match breakdownBuy Signal & Weekly High Potential Stock Alerts - Улправда
How StealthGas Inc. stock responds to policy changesDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Will Mustang Bio Inc. stock deliver better than expected guidanceEarnings Trend Report & Fast Gaining Stock Strategy Reports - Улправда
Will Mustang Bio Inc. stock deliver long term returns2025 Institutional Moves & Safe Entry Momentum Stock Tips - Улправда
ulpravda ru > 2026> Will LTRY stock continue dividend increasesLong Setup & Comprehensive Market Scan Insights - Улправда
Why Belite Bio Inc (Common Stock) (D01) stock appears on watchlists2025 Volatility Report & Safe Swing Trade Setup Alerts - Улправда
Why Mustang Bio Inc. stock is seen as undervaluedEarnings Growth Summary & Weekly High Return Stock Opportunities - Улправда
Why Atkore Inc. stock attracts strong analyst attention - ulpravda.ru
Is Mustang Bio Inc. stock positioned for long term growthQuarterly Trade Review & Growth-Oriented Investment Plans - ulpravda.ru
City of Hope and Cellares to automate manufacturing of solid tumor CAR T cell therapy - EurekAlert!
Aug Technicals: Will Mustang Bio Inc stock gain from strong economy2025 Key Highlights & Free Daily Entry Point Trade Alerts - Bộ Nội Vụ
Morning Market Movers: CYCN, AZI, AEVA, OS See Big Swings - RTTNews
Is Mustang Bio Inc a good long term investmentMarket Sentiment Shifts & Learn to Think Like a Long-Term Investor - earlytimes.in
Support Zone Holds Steady for Jagran Prakashan Limited After DipLong-Term Investment Plans & Free Exceptional Risk Adjusted Gains - bollywoodhelpline.com
Is Mustang Bio Inc. stock near bottom after declineMarket Entry Points & Investment Risk Management Tips - bollywoodhelpline.com
Mustang Bio (NASDAQ:MBIO) versus Agios Pharmaceuticals (NASDAQ:AGIO) Critical Comparison - Defense World
Mustang Bio Shareholders Approve Equity Plans and Directors - TipRanks
Mustang Bio shareholders approve equity plans and directors - MSN
Is Mustang Bio Inc. stock cheap at current valuation2025 Growth vs Value & Trade Opportunity Analysis - Улправда
Will Mustang Bio Inc. stock reach Wall Street targetsMarket Weekly Review & Accurate Buy Signal Notifications - Улправда
Market Pulse: Is Mustang Bio Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Volume Triggers - moha.gov.vn
Whale Trades: Why BKN stock stays resilientPortfolio Performance Report & Free Daily Entry Point Trade Alerts - moha.gov.vn
How Mustang Bio Inc. stock reacts to global recession fearsQuarterly Earnings Report & Long-Term Safe Investment Plans - Улправда
Macro Review: Will Mustang Bio Inc. stock gain from strong economyWatch List & AI Driven Stock Reports - moha.gov.vn
Quarterly Recap: How Mustang Bio Inc. stock reacts to global recession fearsJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Mustang Bio Earnings Notes - Trefis
Is GSPRD a good long term investmentRetail Trading Trends & Low Cost Wealth Building - earlytimes.in
Tech Rally: Can Mustang Bio Inc stock sustain revenue growthJuly 2025 Price Swings & Weekly High Return Stock Opportunities - BỘ NỘI VỤ
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):